Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Ramaekers

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Health Technology Assessment (Winchester, England)|June 1, 2021
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluationMarie Westwood, Bram Ramaekers, Sabine Grimm, et al.
Health Technology Assessment (Winchester, England)|November 17, 2015
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysisMarie Westwood, Bram Ramaekers, Penny Whiting, et al.
Pharmacoeconomics|November 19, 2015
Use of Value of Information in Healthcare Decision Making: Exploring Multiple PerspectivesJill Bindels, Bram Ramaekers, Isaac Corro Ramos, et al.
Health Technology Assessment (Winchester, England)|June 30, 2015
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Clinical Drug Investigation|July 9, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term SurvivorsZakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen, et al.
Journal of Experimental Orthopaedics|December 19, 2024
Forecasting the value of innovation in total knee arthroplasty care: A headroom approachThomas M Otten, Sabine E Grimm, Bram Ramaekers, et al.
Health Technology Assessment (Winchester, England)|October 15, 2014
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Pharmacoeconomics|September 22, 2017
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related ResearchThea van Asselt, Bram Ramaekers, Isaac Corro Ramos, et al.
Pharmacoeconomics|April 3, 2020
R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case StudyRose Hart, Darren Burns, Bram Ramaekers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2017
Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectivenessYvonka van Wijk, Ben G L Vanneste, Sean Walsh, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Health Technology Assessment (Winchester, England)|June 1, 2021
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluationMarie Westwood, Bram Ramaekers, Sabine Grimm, et al.
Health Technology Assessment (Winchester, England)|November 17, 2015
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysisMarie Westwood, Bram Ramaekers, Penny Whiting, et al.
Pharmacoeconomics|November 19, 2015
Use of Value of Information in Healthcare Decision Making: Exploring Multiple PerspectivesJill Bindels, Bram Ramaekers, Isaac Corro Ramos, et al.
Health Technology Assessment (Winchester, England)|June 30, 2015
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Clinical Drug Investigation|July 9, 2025
Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term SurvivorsZakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen, et al.
Journal of Experimental Orthopaedics|December 19, 2024
Forecasting the value of innovation in total knee arthroplasty care: A headroom approachThomas M Otten, Sabine E Grimm, Bram Ramaekers, et al.
Health Technology Assessment (Winchester, England)|October 15, 2014
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Pharmacoeconomics|September 22, 2017
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related ResearchThea van Asselt, Bram Ramaekers, Isaac Corro Ramos, et al.
Pharmacoeconomics|April 3, 2020
R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case StudyRose Hart, Darren Burns, Bram Ramaekers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2017
Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectivenessYvonka van Wijk, Ben G L Vanneste, Sean Walsh, et al.
Pageof 4